All News

Genentech's $1.7 billion acquisition of Seargon Pharmaceutical includes portfolio of investigational next-generation oral selective estrogen receptor degraders.

Several groups, including pharmacies, call on FDA to preserve accepted International Nonproprietary Name conventions for biosimilars.

BIO 2014 hosted more than 29,000 one-to-one partnering meetings.

The collaboration will use Mersana Therapeutics Fleximer technology for antibody-drug conjugates.

European Medicines Agency clarifies advanced-therapy medicinal products classification.

FDA releases guidance documents and rules on requirements for compounding human drug products.

Merck funds Bionomics with $20 million to progress therapies for cognitive impairment caused by central nervous system disorders

Bristol-Myers Squibb issues a voluntary US recall of Coumadin (warfarin sodium) for injection due to presence of particulate matter.

GSK and Save the Children announce criteria for awards that recognize innovation in healthcare for the world"s poorest children.

Covance MarketPlace is designed to enable partnerships between the company's emerging biotechnology and established pharmaceutical clients.

New toxicology study demonstrates decreased mortality and better tolerability of ADC generated with Smartag platform versus conventional technology.

Cytovance Biologics completes GMP manufacture of ARMO BioSciences' lead product.

Aesica Pharmaceuticals S.r.I. collaborates with QAD to meet China's Food and Drug Administration's shortened serialization deadline.

Rentschler plans to build two stainless-steel bioreactors to target market supply.

Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.

PhRMA announced 430 new medicines in development to treat chronic diseases affecting older Americans.

GSK Biologicals receives warning about cGMP compliance issues at its Quebec facility.

According to the National Bioscience Report, the US bioscience industry is on course for continued growth.

FDA approved Cubist's treatment for skin infections including MRSA.

NIH launched 3D Print Exchange, a public website promoting health and science applications of 3D printing.

Shire reports that AbbVie offer undervalued company.

Arecor and the Center for Process Innovation (CPI) Biologics are working on a project to enhance the compatibility of biologics with their containers.

FDA cites cGMP violations for API manufacturing at a facility in Tianjin, China.

New services manage clinical or drug manufacturing data in the Verizon cloud or from data centers.

EDQM details the agency?s accomplishments in 2013.

Big pharma employment dropped by 3% between 2003 and 2013, according to a new jobs report published by EP Vantage.

FDA inspection found cGMP violations in the Bangalore, India API manufacturing facility.

The National Institutes of Health and the National Science Foundation set up biomedical innovation and business program.

FDA issues guidance on the use of social media in regards to prescription drugs.

Hospira announces a voluntary nationwide recall due to particulates from a glass defect.